Repaglinide is an antidiabetic drug in the class of medications known as
meglitinides, and was invented in 1983. Repaglinide is an oral medication used
PRANDIN® (repaglinide) is an oral blood glucose-lowering drug of the
meglitinide class used in the management of type 2 diabetes mellitus (also
known as ...
Find patient medical information for repaglinide oral on WebMD including its
uses, side effects and safety, interactions, pictures, warnings and user ratings.
Dec 11, 2014 ... Information about repaglinide (Prandin), a drug prescribed for the treatment of
high blood sugar (glucose) in patient's with diabetes.
Repaglinide lowers blood glucose by encouraging your pancreas to produce
more insulin. It works quickly so is particularly helpful in controlling blood sugar ...
Repaglinide is a nonsulfonylurea insulin secretagogue belonging to the
melgitinide class with hypoglycemic activity. Repaglinide is rapidly absorbed and
has a ...
Jul 11, 2016 ... Repaglinide is indicated in adults with type 2 diabetes mellitus whose
hyperglycaemia can no longer be controlled satisfactorily by diet, weight ...
Apr 17, 2015 ... Repaglinide (Prandin) is used to treat people with type 2 diabetes who can't
manage their condition by diet and exercise alone.
Repaglinide is an antidiabetic drug that belongs to meglitinide category. The
mechanism of action of repaglinide is to lower blood glucose levels by blocking ...
Repaglinide is used to treat type 2 diabetes. When you have type 2 diabetes,
insulin is still being produced by your pancreas. Sometimes the amount of insulin